## **Core Concept**
The International Federation of Gynecology and Obstetrics (FIGO) staging system is used to classify the extent of spread of gynecologic cancers, including ovarian cancer. It helps in determining the prognosis and treatment plan. The staging is based on the extent of tumor spread, including the size and location of the tumor, involvement of lymph nodes, and presence of distant metastases.

## **Why the Correct Answer is Right**
The correct answer, **Stage IIIC**, indicates that the carcinoma is limited to the true pelvis but has microscopic implants on the peritoneal surface outside the pelvis and/or regional lymph node metastasis. The presence of microscopic implants on the peritoneal surface, even if the cancer is still within the true pelvis and without positive lymph nodes, classifies it as Stage IIIC. This stage signifies a more advanced local spread that requires comprehensive treatment planning.

## **Why Each Wrong Option is Incorrect**
- **Option A (Stage I):** This stage refers to tumors limited to the ovaries, which does not match the description given, as the scenario includes microscopic implants on the peritoneal surface.
- **Option B (Stage II):** This stage involves tumor involving one or both ovaries with pelvic extension, but it does not include microscopic peritoneal implants outside the pelvis or positive nodes.
- **Option D (Stage IV):** This stage involves distant metastasis, which is not indicated in the scenario provided, as it only mentions involvement within the true pelvis and microscopic implants on the peritoneal surface.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the FIGO staging of ovarian cancer is primarily based on surgical findings. The presence of microscopic implants on the peritoneal surface significantly affects the staging and prognosis. For ovarian cancer, comprehensive surgical staging, including peritoneal biopsies and assessment of lymph nodes, is crucial for accurate FIGO staging.

## **Correct Answer:** .